0.00Open0.00Pre Close0 Volume0 Open Interest40.00Strike Price0.00Turnover319.48%IV-50.49%PremiumDec 20, 2024Expiry Date13.42Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8096Delta0.0268Gamma1.86Leverage Ratio-0.2576Theta-0.0045Rho-1.50Eff Leverage0.0086Vega
Calavo Growers Stock Discussion
Gapping up
$Eli Lilly and Co (LLY.US)$ shares rose 2% after a panel of FDA advisors recommended the approval of its Alzheimer's drug known as donanemab.
$General Motors (GM.US)$ The automaker's stock added more than 1% after its board authorized a $6 billion stock buyback program.
$Shopify (SHOP.US)$ The e-commerce stock rose about 1% after JPMorgan initiated coverage with an overweight rating, stating that the recen...
A GameStop $GameStop (GME.US)$ director just made the first open-market stock purchase this year, while the CEOs of department-store chain Kohl’s $Kohl's Corp (KSS.US)$ and avocado slinger Calavo Growers CVGW $Calavo Growers (CVGW.US)$ picked up millions of dollars of stock.
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet